Selectra Investments Sicav

The sub-fund aims at benefiting from increasing share prices in the biotechnology sector. 

The sub-fund aims at benefiting from increasing share prices in the pharmaceutical sector worldwide. 

The sub-fund aims at generating a capital growth and at providing income over the medium term by investing mainly in European and United States equities and fixed income securities. 

The sub-fund is actively managed and it does not make reference to any index. The objective of the sub-fund is to achieve capital growth by combining different eligible assets and investing principally in a portfolio of UCITS, UCITS Exchange Traded Funds (ETF) and other UCIs (the “Target Funds”), which respectively may invest mainly in cash and cash-linked instruments, bond, equity and equity-linked instruments. 

The sub-fund shall be actively managed with the objective of obtaining capital growth by investing in liquid equities listed on the main stock exchange markets of Europe, Asia and the US and in a diversified range of debt securities of any kind, including but not limited to government bonds, investment-grade bonds, high yield bonds (up to 30% of the NAV), convertible bonds, floating-rate notes, inflation-linked bonds/notes and money market instruments, issued or guaranteed by sovereign, supranational or corporate issuers, denominated in any currency.